Doha: Officially opened in April 2016 by Her Excellency Dr. Hanan Mohamed Al Kuwari, Minister of Public Health, Hamad Medical Corporation’s (HMC) Neuroangiography Suite has offered improved treatment outcomes for hundreds of patients with serious vascular disorders in the brain and spinal cord.

The new facility has boosted HMC’s ability to deliver minimally invasive treatment of vascular problems in the brain and spine, known as Interventional Neuroradiology (INR). These procedures are provided by the Neuroradiology Department and have resulted in a marked improvement in the quality of care and outcomes for both pediatric and adult patients since 2015.

“More than 250 patients have received treatment, including many life-saving procedures since operations first began in the Neuroangiography Suite. These include minimally invasive endovascular treatments for brain and spine vascular disorders and procedures to remove blood clots from brain arteries,” said Dr. Ayman Zakaria, Senior Consultant, Interventional Neuroradiology at Hamad General Hospital.

“The treatment options for these patients have improved enormously due to the technology available in the new suite. Patients with tumors, vascular malformations, cerebral aneurysms, as well as children with developmental vascular disorders in the brain, have been among those to benefit from the cutting-edge technology in this new facility,” explained Dr. Zakaria.

“For patients with acute stroke, we are now able to perform a procedure known as mechanical thrombectomy, where we introduce a thin catheter through the artery of the groin up to the brain and physically remove the clot that blocks the arteries to the brain. Before the introduction of this technique, the only treatment option available for acute stroke patients was to inject a clot-busting drug. This option is far less effective than the mechanical thrombectomy procedure,” explained Dr. Zakaria.

One of the key benefits of the new suite is the advanced capability of bi-plane angiography and CT like imaging. Dr. Ahmed Own, Chairman of Neuroradiology at HMC, explained that this imaging technique allows neuro-interventional teams to view the inside of blood vessels and organs in greater detail.

“This advanced imaging gives them the very best view of the arteries and veins and allows them to see their precise location and determine the strategy for treatment while they perform the procedure,” explained Dr. Own.

Five children below two years of age have been treated with life-saving procedures in the Neuroangiography Suite. These infants suffered from a condition known as Vein of Galen Malformation, a rare condition that occurs during pregnancy and results in abnormal connections between blood vessels within the brain.

“The technology within the Suite enabled us to correct these abnormalities in the infants’ developing brains and gave them the chance to thrive and live a healthy life. Without this technology, we would not be able to fix these conditions and these infants would have been left with a great risk of bleeding and death,” explained Dr. Own.

The number of cases treated in the Neuroangiography Suite has risen each year due to the increased number of patients with stroke and vascular conditions of the brain and spine in Qatar.

“Each year we are seeing more and more stroke patients admitted to our hospitals,” explained Professor Ashfaq Shuaib, Director of HMC’s Neurosciences Institute. “It is no exaggeration to say that procedures performed in the Neuroangiography Suite have saved the lives of many patients. Without this technology, it was simply not possible to provide the same level of treatment.”

-Ends-

About Hamad Medical Corporation 

Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East.

For more than three decades, HMC has been dedicated to delivering the safest, most effective and compassionate care to all its patients.

HMC manages twelve hospitals – nine specialist hospitals and three community hospitals – as well as the National Ambulance Service and home and residential care services.

In January 2016, HMC achieved the significant distinction of becoming the first healthcare system across the globe to have all its hospitals accredited by Joint Commission International under the Academic Medical Center accreditation program. Additionally, the National Ambulance Service, Home Healthcare Service, Stroke Service and Palliative Care, have all received this prestigious accreditation since 2011.

To meet the needs of a rapidly growing population, HMC has announced ambitious plans to expand capacity across its network through to 2030.

HMC is leading the development of the region’s first academic health system – combining innovative research, top-class education and excellent clinical care – and is committed to building a legacy of healthcare expertise in Qatar. HMC collaborates with key partners who are experts in Qatar and beyond, including Weill Cornell Medical College-Qatar, the Institute for Healthcare Improvement and Partners Healthcare, Boston.

HMC is also the first hospital system in the Middle East to achieve institutional accreditation from the Accreditation Council of Graduate Medical Education – International (ACGME-I), which demonstrates excellence in the way medical graduates are trained through residency, internship and fellowship programs.

For more information please visit: www.hamad.qa or contact Noimot Olayiwola, Media Project Manager Tel: (00974) 44390945; Mobile: (00974) 55568709; Email: nolayiwola@hamad.qa  

© Press Release 2018

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.